Cellebrite DI (CLBT) Equity Average (2020 - 2025)

Cellebrite DI has reported Equity Average over the past 6 years, most recently at $410.2 million for Q4 2025.

  • Quarterly results put Equity Average at $410.2 million for Q4 2025, up 121.57% from a year ago — trailing twelve months through Dec 2025 was $410.2 million (up 121.57% YoY), and the annual figure for FY2025 was $410.2 million, up 121.57%.
  • Equity Average for Q4 2025 was $410.2 million at Cellebrite DI, up from $185.1 million in the prior quarter.
  • Over the last five years, Equity Average for CLBT hit a ceiling of $410.2 million in Q4 2025 and a floor of -$4.8 million in Q4 2021.
  • Median Equity Average over the past 5 years was $54.0 million (2023), compared with a mean of $129.0 million.
  • Biggest five-year swings in Equity Average: plummeted 107.78% in 2021 and later skyrocketed 20764.29% in 2023.
  • Cellebrite DI's Equity Average stood at -$4.8 million in 2021, then soared by 105.43% to $259000.0 in 2022, then skyrocketed by 20764.29% to $54.0 million in 2023, then skyrocketed by 242.56% to $185.1 million in 2024, then soared by 121.57% to $410.2 million in 2025.
  • The last three reported values for Equity Average were $410.2 million (Q4 2025), $185.1 million (Q4 2024), and $54.0 million (Q4 2023) per Business Quant data.